Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Shafi

Showing results (111-120 of 139) with videos related to

Pageof 14
Sort By:
Global Spine Journal|May 11, 2026
Long-Term Range of Motion and Influence on Clinical Outcomes After Lumbar Disc Replacement: A Systematic ReviewTejas Subramanian, Stephane Owusu-Sarpong, Adrian T H Lu, et al.
Targeted Oncology|December 11, 2025
Beyond Proton Pump Inhibitors: Evaluating Treatment Strategies for Immune-Mediated Gastroenteritis from Cancer ImmunotherapyCarolina Colli Cruz, Maria Julia Moura Nascimento Santos, Sharada Wali, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancerSumaira Sardar, Christopher M McNair, Lakshmi Ravindranath, et al.
Annals of Gastroenterology|March 23, 2026
Efficacy of current therapeutic strategies for immune checkpoint inhibitor-related esophagitisCarolina Colli Cruz, Maria Julia M N Santos, Sharada Wali, et al.
Nature Communications|January 16, 2021
The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repairAyesha A Shafi, Chris M McNair, Jennifer J McCann, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate CancerBeatriz German, Katherine L Morel, Teia Noel, et al.
Oncogene|September 12, 2024
AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancerSumaira Sardar, Christopher M McNair, Lakshmi Ravindranath, et al.
Molecular Oncology|September 7, 2025
PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration-resistant prostate cancerMoriah L Cunningham, Jasibel Vasquez-Gonzalez, Samantha M Barnada, et al.
Gastrointestinal Endoscopy|April 26, 2015
Natural language processing as an alternative to manual reporting of colonoscopy quality metricsGottumukkala S Raju, Phillip J Lum, Rebecca S Slack, et al.
Cancer Discovery|April 21, 2021
RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced DiseaseAmy C Mandigo, Wei Yuan, Kexin Xu, et al.
Pageof 14

Showing results (111-120 of 139) with videos related to

Sort By:
Pageof 14
Global Spine Journal|May 11, 2026
Long-Term Range of Motion and Influence on Clinical Outcomes After Lumbar Disc Replacement: A Systematic ReviewTejas Subramanian, Stephane Owusu-Sarpong, Adrian T H Lu, et al.
Targeted Oncology|December 11, 2025
Beyond Proton Pump Inhibitors: Evaluating Treatment Strategies for Immune-Mediated Gastroenteritis from Cancer ImmunotherapyCarolina Colli Cruz, Maria Julia Moura Nascimento Santos, Sharada Wali, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancerSumaira Sardar, Christopher M McNair, Lakshmi Ravindranath, et al.
Annals of Gastroenterology|March 23, 2026
Efficacy of current therapeutic strategies for immune checkpoint inhibitor-related esophagitisCarolina Colli Cruz, Maria Julia M N Santos, Sharada Wali, et al.
Nature Communications|January 16, 2021
The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repairAyesha A Shafi, Chris M McNair, Jennifer J McCann, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate CancerBeatriz German, Katherine L Morel, Teia Noel, et al.
Oncogene|September 12, 2024
AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancerSumaira Sardar, Christopher M McNair, Lakshmi Ravindranath, et al.
Molecular Oncology|September 7, 2025
PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration-resistant prostate cancerMoriah L Cunningham, Jasibel Vasquez-Gonzalez, Samantha M Barnada, et al.
Gastrointestinal Endoscopy|April 26, 2015
Natural language processing as an alternative to manual reporting of colonoscopy quality metricsGottumukkala S Raju, Phillip J Lum, Rebecca S Slack, et al.
Cancer Discovery|April 21, 2021
RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced DiseaseAmy C Mandigo, Wei Yuan, Kexin Xu, et al.
Pageof 14